Michael Richman insider trades

Open-market stock purchases and sales by Michael Richman, President & CEO at NextCure, Inc, from SEC Form 4 filings since Apr 30, 2010.

Recent trades

DateStockTradeValue
Jan 30, 2026NXTC NextCure, IncBought (not open market)—

Companies traded

  • NXTC NextCure, Inc: other filings, last Jan 30, 2026
  • PIRS Pieris Pharmaceuticals, Inc: other filings, last Jun 21, 2023
  • GNVC Genvec Inc: other filings, last Jun 16, 2017
  • OPXA Opexa Therapeutics, Inc: other filings, last Sep 30, 2016

Get free alerts when Michael Richman files a new trade →